Phibro Animal Health Stock Price To Book

PAHC Stock

USD 16.70 0.08 0.48%

Phibro Animal Health fundamentals help investors to digest information that contributes to Phibro Animal's financial success or failures. It also enables traders to predict the movement of Phibro Stock. The fundamental analysis module provides a way to measure Phibro Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phibro Animal stock.

Short Long Term Debt Total Total Assets

The current year's Price To Book Ratio is expected to grow to 3.26.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Phibro Animal Health Company Price To Book Analysis

Phibro Animal's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Phibro Animal Price To Book

1.96 X

Most of Phibro Animal's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Phibro Price To Book Driver Correlations

Understanding the fundamental principles of building solid financial models for Phibro Animal is extremely important. It helps to project a fair market value of Phibro Stock properly, considering its historical fundamentals such as Price To Book. Since Phibro Animal's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Phibro Animal's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Phibro Animal's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Tangible Assets	Current Deferred Revenue	Short Term Investments	Deferred Long Term Liab	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.91	0.72	0.9	0.68	0.66	0.75	0.74	0.8	0.84	0.63	-0.22	0.79	0.96	0.94	0.33	0.68	0.21	-0.66	0.67	0.91	0.88	0.87	0.87	-0.65
Total Stockholder Equity	0.91		0.54	0.98	0.53	0.43	0.78	0.54	0.76	0.86	0.64	-0.54	0.75	0.92	0.96	0.3	0.73	0.31	-0.76	0.57	0.89	0.92	0.81	0.82	-0.52
Net Debt	0.72	0.54		0.55	0.77	0.67	0.77	0.97	0.89	0.6	0.67	0.14	0.9	0.72	0.59	0.38	0.59	0.01	-0.38	0.85	0.72	0.67	0.84	0.82	-0.19
Retained Earnings	0.9	0.98	0.55		0.51	0.49	0.75	0.54	0.75	0.91	0.61	-0.51	0.76	0.93	0.95	0.31	0.76	0.24	-0.71	0.63	0.9	0.91	0.83	0.84	-0.52
Accounts Payable	0.68	0.53	0.77	0.51		0.48	0.81	0.88	0.86	0.48	0.62	0.18	0.72	0.62	0.61	0.06	0.4	0.19	-0.48	0.59	0.62	0.59	0.69	0.71	-0.12
Long Term Debt	0.66	0.43	0.67	0.49	0.48		0.33	0.61	0.48	0.67	0.15	0.15	0.53	0.67	0.5	0.27	0.4	-0.41	0.08	0.76	0.64	0.38	0.73	0.7	-0.55
Net Receivables	0.75	0.78	0.77	0.75	0.81	0.33		0.8	0.96	0.63	0.74	-0.24	0.9	0.72	0.8	0.31	0.64	0.26	-0.66	0.62	0.8	0.84	0.82	0.85	-0.12
Total Liab	0.74	0.54	0.97	0.54	0.88	0.61	0.8		0.91	0.55	0.72	0.24	0.88	0.71	0.61	0.32	0.57	0.1	-0.46	0.76	0.7	0.69	0.79	0.78	-0.17
Total Current Assets	0.8	0.76	0.89	0.75	0.86	0.48	0.96	0.91		0.69	0.78	-0.08	0.96	0.79	0.79	0.33	0.71	0.23	-0.64	0.73	0.82	0.84	0.86	0.87	-0.14
Short Term Debt	0.84	0.86	0.6	0.91	0.48	0.67	0.63	0.55	0.69		0.45	-0.41	0.72	0.89	0.84	0.3	0.78	0.04	-0.49	0.75	0.87	0.77	0.85	0.84	-0.5
Intangible Assets	0.63	0.64	0.67	0.61	0.62	0.15	0.74	0.72	0.78	0.45		-0.14	0.8	0.7	0.56	0.2	0.65	0.38	-0.8	0.5	0.57	0.8	0.51	0.49	0.04
Common Stock	-0.22	-0.54	0.14	-0.51	0.18	0.15	-0.24	0.24	-0.08	-0.41	-0.14		-0.16	-0.31	-0.35	-0.11	-0.25	-0.26	0.39	-0.16	-0.31	-0.36	-0.25	-0.26	0.22
Property Plant Equipment	0.79	0.75	0.9	0.76	0.72	0.53	0.9	0.88	0.96	0.72	0.8	-0.16		0.83	0.75	0.49	0.77	0.17	-0.6	0.83	0.83	0.85	0.87	0.86	-0.16
Good Will	0.96	0.92	0.72	0.93	0.62	0.67	0.72	0.71	0.79	0.89	0.7	-0.31	0.83		0.89	0.33	0.76	0.2	-0.66	0.76	0.9	0.88	0.86	0.84	-0.54
Net Tangible Assets	0.94	0.96	0.59	0.95	0.61	0.5	0.8	0.61	0.79	0.84	0.56	-0.35	0.75	0.89		0.31	0.71	0.27	-0.69	0.54	0.91	0.89	0.84	0.86	-0.57
Current Deferred Revenue	0.33	0.3	0.38	0.31	0.06	0.27	0.31	0.32	0.33	0.3	0.2	-0.11	0.49	0.33	0.31		0.29	0.05	-0.2	0.4	0.41	0.35	0.4	0.4	-0.23
Short Term Investments	0.68	0.73	0.59	0.76	0.4	0.4	0.64	0.57	0.71	0.78	0.65	-0.25	0.77	0.76	0.71	0.29		0.15	-0.57	0.58	0.78	0.75	0.65	0.64	-0.22
Deferred Long Term Liab	0.21	0.31	0.01	0.24	0.19	-0.41	0.26	0.1	0.23	0.04	0.38	-0.26	0.17	0.2	0.27	0.05	0.15		-0.74	-0.04	0.13	0.24	0.06	0.07	-0.01
Short Long Term Debt	-0.66	-0.76	-0.38	-0.71	-0.48	0.08	-0.66	-0.46	-0.64	-0.49	-0.8	0.39	-0.6	-0.66	-0.69	-0.2	-0.57	-0.74		-0.29	-0.56	-0.79	-0.45	-0.46	0.18
Long Term Debt Total	0.67	0.57	0.85	0.63	0.59	0.76	0.62	0.76	0.73	0.75	0.5	-0.16	0.83	0.76	0.54	0.4	0.58	-0.04	-0.29		0.73	0.59	0.88	0.83	-0.28
Capital Surpluse	0.91	0.89	0.72	0.9	0.62	0.64	0.8	0.7	0.82	0.87	0.57	-0.31	0.83	0.9	0.91	0.41	0.78	0.13	-0.56	0.73		0.85	0.92	0.92	-0.6
Long Term Investments	0.88	0.92	0.67	0.91	0.59	0.38	0.84	0.69	0.84	0.77	0.8	-0.36	0.85	0.88	0.89	0.35	0.75	0.24	-0.79	0.59	0.85		0.78	0.78	-0.37
Net Invested Capital	0.87	0.81	0.84	0.83	0.69	0.73	0.82	0.79	0.86	0.85	0.51	-0.25	0.87	0.86	0.84	0.4	0.65	0.06	-0.45	0.88	0.92	0.78		1.0	-0.48
Net Working Capital	0.87	0.82	0.82	0.84	0.71	0.7	0.85	0.78	0.87	0.84	0.49	-0.26	0.86	0.84	0.86	0.4	0.64	0.07	-0.46	0.83	0.92	0.78	1.0		-0.48
Capital Stock	-0.65	-0.52	-0.19	-0.52	-0.12	-0.55	-0.12	-0.17	-0.14	-0.5	0.04	0.22	-0.16	-0.54	-0.57	-0.23	-0.22	-0.01	0.18	-0.28	-0.6	-0.37	-0.48	-0.48

Click cells to compare fundamentals

Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Competition

Predict Phibro Animal

Price Book Value Ratio Over Time

Phibro Book Value Per Share

Book Value Per Share

6.59

At present, Phibro Animal's Book Value Per Share is projected to increase based on the last few years of reporting.

Based on the latest financial disclosure, Phibro Animal Health has a Price To Book of 1.9608 times. This is 92.36% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to book for all United States stocks is 79.38% higher than that of the company.

Phibro Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phibro Animal's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phibro Animal could also be used in its relative valuation, which is a method of valuing Phibro Animal by comparing valuation metrics of similar companies.

Phibro Animal is currently under evaluation in price to book category among related companies.

Phibro Fundamentals

	Return On Equity	0.0549
	Return On Asset	0.0372
	Profit Margin	0.02 %
	Operating Margin	0.06 %
	Current Valuation	1.09 B
	Shares Outstanding	20.34 M
	Shares Owned By Insiders	0.62 %
	Shares Owned By Institutions	99.38 %
	Number Of Shares Shorted	626.54 K
	Price To Earning	11.39 X
	Price To Book	1.96 X
	Price To Sales	0.54 X
	Revenue	977.89 M
	Gross Profit	298.24 M
	EBITDA	108.49 M
	Net Income	32.61 M
	Cash And Equivalents	98.67 M
	Cash Per Share	2.44 X
	Total Debt	509.97 M
	Debt To Equity	1.79 %
	Current Ratio	2.97 X
	Book Value Per Share	6.69 X
	Cash Flow From Operations	13.31 M
	Short Ratio	4.82 X
	Earnings Per Share	0.37 X
	Price To Earnings To Growth	1.66 X
	Target Price	10.75
	Number Of Employees	1.92 K
	Beta	0.74
	Market Capitalization	679.65 M
	Total Asset	971.4 M
	Retained Earnings	260.91 M
	Working Capital	409.72 M
	Current Asset	342.83 M
	Current Liabilities	108.78 M
	Annual Yield	0.03 %
	Five Year Return	1.85 %
	Net Asset	971.4 M
	Last Dividend Paid	0.48

About Phibro Animal Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Phibro Animal Health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:

How To Invest In Phibro

Details

Is Phibro Stock a good investment?

Details

What is Phibro Animal's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Phibro Animal Piotroski F Score and Phibro Animal Altman Z Score analysis.

Note that the Phibro Animal Health information on this page should be used as a complementary analysis to other Phibro Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Phibro Stock analysis

When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.

	Global Correlations Find global opportunities by holding instruments from different markets
	Commodity Directory Find actively traded commodities issued by global exchanges
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Stocks Directory Find actively traded stocks across global markets
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	CEOs Directory Screen CEOs from public companies around the world
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities

Is Phibro Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.83)

Dividend Share

0.48

Earnings Share

0.37

Revenue Per Share

24.245

Quarterly Revenue Growth

0.022

The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Phibro Animal Health Stock Price To Book

Phibro Animal Health Company Price To Book Analysis

P/B

MV Per Share

BV Per Share

Current Phibro Animal Price To Book

Phibro Price To Book Driver Correlations

Phibro Book Value Per Share

Book Value Per Share

6.59

Phibro Price To Book Peer Comparison

Phibro Fundamentals

About Phibro Animal Fundamental Analysis

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Phibro Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY